+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioprocess Technology Market Research Report by Product, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 151 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5721353
The United States Bioprocess Technology Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Bioprocess Technology Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Bioprocess Technology Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Bioprocess Technology Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Bioprocess Technology Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Bioprocess Technology Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Bioprocess Technology Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Consumables & Accessories and Instruments. The Consumables & Accessories is is further studied across Culture Media and Reagents. The Instruments is is further studied across Bioprocess Analyzers, Bioreactors, Blood Gas Analyzers, Cell Counter, Incubators, and Osmometers.
  • Based on Application, the market is studied across Antibiotics, Biosimilar, Monoclonal Antibodies, Primary Surgical, and Recombinant Proteins.
  • Based on End-User, the market is studied across Academic Research Organization, Biopharmaceutical Companies, Contract Manufacturing Organization, Contract Research Organization, and Food & Feed Industry.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Bioprocess Technology Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Bioprocess Technology Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Bioprocess Technology Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Bioprocess Technology Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Bioprocess Technology Market, including Asahi Kasei Medical Co., Ltd., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Colder Products Company, Emerson Electric Co., Eppendorf SE, F. Hoffmann-La Roche AG, Getinge AB, Koninklijke Philips N.V., Lonza Group AG, Merck KGaA, Sartorious AG, Solida Biotech GmBH, STADA Arzneimittel AG, and Univercells Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Bioprocess Technology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Bioprocess Technology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Bioprocess Technology Market?
4. What is the competitive strategic window for opportunities in the United States Bioprocess Technology Market?
5. What are the technology trends and regulatory frameworks in the United States Bioprocess Technology Market?
6. What is the market share of the leading vendors in the United States Bioprocess Technology Market?
7. What modes and strategic moves are considered suitable for entering the United States Bioprocess Technology Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for new food flavors and ingredients
5.1.1.2. Increasing adoption of cell culture bioprocess technology
5.1.2. Restraints
5.1.2.1. Dearth of skilled workers
5.1.3. Opportunities
5.1.3.1. Improvements and advances in bioprocess technology
5.1.4. Challenges
5.1.4.1. Operational limitations of bioprocess technology
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Bioprocess Technology Market, by Product
6.1. Introduction
6.2. Consumables & Accessories
6.3.1. Culture Media
6.3.2. Reagents
6.3. Instruments
6.4.1. Bioprocess Analyzers
6.4.2. Bioreactors
6.4.3. Blood Gas Analyzers
6.4.4. Cell Counter
6.4.5. Incubators
6.4.6. Osmometers

7. Bioprocess Technology Market, by Application
7.1. Introduction
7.2. Antibiotics
7.3. Biosimilar
7.4. Monoclonal Antibodies
7.5. Primary Surgical
7.6. Recombinant Proteins

8. Bioprocess Technology Market, by End-User
8.1. Introduction
8.2. Academic Research Organization
8.3. Biopharmaceutical Companies
8.4. Contract Manufacturing Organization
8.5. Contract Research Organization
8.6. Food & Feed Industry

9. California Bioprocess Technology Market
9.1. Introduction

10. Florida Bioprocess Technology Market
10.1. Introduction

11. Illinois Bioprocess Technology Market
11.1. Introduction

12. New York Bioprocess Technology Market
12.1. Introduction

13. Ohio Bioprocess Technology Market
13.1. Introduction

14. Pennsylvania Bioprocess Technology Market
14.1. Introduction

15. Texas Bioprocess Technology Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Asahi Kasei Medical Co., Ltd.
17.2. Becton Dickinson and Company
17.3. Boehringer Ingelheim International GmbH
17.4. Colder Products Company
17.5. Emerson Electric Co.
17.6. Eppendorf SE
17.7. F. Hoffmann-La Roche AG
17.8. Getinge AB
17.9. Koninklijke Philips N.V.
17.10. Lonza Group AG
17.11. Merck KGaA
17.12. Sartorious AG
17.13. Solida Biotech GmBH
17.14. STADA Arzneimittel AG
17.15. Univercells Group

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES BIOPROCESS TECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES BIOPROCESS TECHNOLOGY MARKET DYNAMICS
FIGURE 8. UNITED STATES BIOPROCESS TECHNOLOGY MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES BIOPROCESS TECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CULTURE MEDIA, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPROCESS ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BLOOD GAS ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CELL COUNTER, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INCUBATORS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY OSMOMETERS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 23. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES BIOPROCESS TECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 25. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOSIMILAR, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRIMARY SURGICAL, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. UNITED STATES BIOPROCESS TECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 33. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH ORGANIZATION, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY FOOD & FEED INDUSTRY, 2018-2030 (USD MILLION)
FIGURE 38. CALIFORNIA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. FLORIDA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. ILLINOIS BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. NEW YORK BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. OHIO BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. PENNSYLVANIA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. TEXAS BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 46. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 47. UNITED STATES BIOPROCESS TECHNOLOGY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CULTURE MEDIA, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CULTURE MEDIA, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY REAGENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPROCESS ANALYZERS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPROCESS ANALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOREACTORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BLOOD GAS ANALYZERS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BLOOD GAS ANALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CELL COUNTER, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CELL COUNTER, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INCUBATORS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY INCUBATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY OSMOMETERS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY OSMOMETERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOSIMILAR, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOSIMILAR, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRIMARY SURGICAL, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRIMARY SURGICAL, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH ORGANIZATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH ORGANIZATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY FOOD & FEED INDUSTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SIZE, BY FOOD & FEED INDUSTRY, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CALIFORNIA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. CALIFORNIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CALIFORNIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CALIFORNIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. FLORIDA BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. FLORIDA BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. FLORIDA BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ILLINOIS BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ILLINOIS BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. NEW YORK BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. OHIO BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. OHIO BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. OHIO BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. OHIO BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. PENNSYLVANIA BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. PENNSYLVANIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. PENNSYLVANIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. PENNSYLVANIA BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. TEXAS BIOPROCESS TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. TEXAS BIOPROCESS TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. TEXAS BIOPROCESS TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. TEXAS BIOPROCESS TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 77. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 78. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 79. UNITED STATES BIOPROCESS TECHNOLOGY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 80. UNITED STATES BIOPROCESS TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 81. UNITED STATES BIOPROCESS TECHNOLOGY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 82. UNITED STATES BIOPROCESS TECHNOLOGY MARKET MERGER & ACQUISITION
TABLE 83. UNITED STATES BIOPROCESS TECHNOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 84. UNITED STATES BIOPROCESS TECHNOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 85. UNITED STATES BIOPROCESS TECHNOLOGY MARKET INVESTMENT & FUNDING
TABLE 86. UNITED STATES BIOPROCESS TECHNOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 87. UNITED STATES BIOPROCESS TECHNOLOGY MARKET: LICENSE & PRICING

Companies Mentioned

  • Asahi Kasei Medical Co., Ltd.
  • Becton Dickinson and Company
  • Boehringer Ingelheim International GmbH
  • Colder Products Company
  • Emerson Electric Co.
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Getinge AB
  • Koninklijke Philips N.V.
  • Lonza Group AG
  • Merck KGaA
  • Sartorious AG
  • Solida Biotech GmBH
  • STADA Arzneimittel AG
  • Univercells Group

Methodology

Loading
LOADING...